|
Lactiplantibacillus plantarum
MON03 |
Toxin detoxification |
Binding via surface structures |
Jebali et al. [156] |
|
Lentilactobacillus kefiri
KFLM3, Saccharomyces cerevisiae KFGY7, Acetobacter
syzygii KFGM1 |
Toxin detoxification |
Adsorption and biotransformation |
Taheur et al. [157] |
|
Lactobacillus helveticus ATCC
12046 |
Toxin detoxification |
Binding via surface structures |
Ismail et al. [158] |
|
Bacillus licheniformis CFR1 |
Toxin detoxification |
Enzymic degradation |
Rao et al. [43] |
|
Saccharomyces cerevisiae HR
125a |
Toxin detoxification |
Binding via surface structures |
Ismail et al. [158] |
|
Lactococcus lactis JF 3102,
Lactiplantibacillus plantarum NRRL B-4496 |
Toxin detoxification |
Binding via surface structures |
Ismail et al. [158] |
|
Streptomyces cacaoi subsp.
asoensis K234, Streptomyces luteogriseus
K144, Streptomyces rimosus K145 |
Toxin detoxification |
Enzymic degradation |
Harkai et al. [159] |
| Several other
Lactobacillus strains |
IgA secretion |
Stimulation of dendritic cells to produce
IL-6 |
Kikuchi et al. [69] |
| IgA secretion |
Stimulation of dendritic cells to produce
TGF-β |
Sakai et al. [160] |
| Enhancement of natural killer (NK) cell
activity |
Stimulation of IL-12 secretion |
Takeda et al. [68] |
| Inhibition of Th2 activity |
Stimulation of IL-12 secretion |
Fujiwara et al. [161] |
| Inhibition of Th2 activity |
Stimulation of activated T-cell death |
Kanzato et al. [162] |
| Improvement of oral tolerance |
Induction of Tregs |
Aoki-Yoshida et al. [163] |
| Reduced inflammation |
Reduced pro-inflammatory cytokines and chemokines
bydown-regulation of TLR-signals |
Shimazu et al. [164] |
| Toxin detoxification |
Binding via surface structures |
Chlebicz and Śliżewska [165] |
| Several other Bifidobacterium
strains |
Reduced inflammation |
Induction of IFN-β |
Kawashima et al. [166] |
| IgA production |
Upregulation of pIgR expression |
Nakamura et al. [167] |
| Modulation of anti-viral activity |
Reduced A20 and improved IRF-3, IFN-β, MxA, and
RNase L |
Ishizuka et al. [168] |
| Protection from enteropathogenic infection |
Production of acetate and enhancement of
intestinal defense with epithelial cells |
Fukuda et al. [169] |
| Allergy inhibition |
Suppression of Th2 chemokines |
Iwabuchi et al. [170] |
| Reduced inflammation |
Inhibition of IL-17 |
Miyauchi et al. [171] |